Vanguard Investments Australia
FLGT icon

Vanguard Investments Australia’s Fulgent Genetics FLGT Stock Holding History

Vanguard Investments Australia’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,355
Closed -$85.1K – 2392
2026
Q1 		$85.1K Buy
+5,355
New +$116K ﹤0.01% 2308

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Investments Australia's FLGT Position: Q2 2026 in Review

Vanguard Investments Australia sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 5,355 shares — an estimated $85.1K sold.

Vanguard Investments Australia first reported a position in FLGT in Q1 2026 and held it in 1 quarter. The position peaked at $85.1K in Q1 2026. 125 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Vanguard Investments Australia reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Vanguard Investments Australia sold 5,355 Fulgent Genetics shares in Q2 2026, an estimated $85.1K.
  • Vanguard Investments Australia first reported a position in Fulgent Genetics in Q1 2026 and held it in 1 quarter.
  • Vanguard Investments Australia's Fulgent Genetics position peaked at $85.1K in Q1 2026.
  • 125 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.